- Home
- ACDC vs AUPH Comparison
ACDC vs AUPH Comparison
Compare ACDC & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACDC
- AUPH
- Stock Information
- Founded
- ACDC 2014
- AUPH 1993
- Country
- ACDC United States
- AUPH Canada
- Employees
- ACDC N/A
- AUPH N/A
- Industry
- ACDC Oilfield Services/Equipment
- AUPH Biotechnology: Pharmaceutical Preparations
- Sector
- ACDC Energy
- AUPH Health Care
- Exchange
- ACDC Nasdaq
- AUPH Nasdaq
- Market Cap
- ACDC 1.1B
- AUPH 1.3B
- IPO Year
- ACDC 2022
- AUPH 1999
- Fundamental
- Price
- ACDC $8.27
- AUPH $8.77
- Analyst Decision
- ACDC Hold
- AUPH Strong Buy
- Analyst Count
- ACDC 6
- AUPH 3
- Target Price
- ACDC $7.60
- AUPH $10.33
- AVG Volume (30 Days)
- ACDC 363.0K
- AUPH 1.3M
- Earning Date
- ACDC 11-05-2024
- AUPH 02-13-2025
- Dividend Yield
- ACDC N/A
- AUPH N/A
- EPS Growth
- ACDC N/A
- AUPH N/A
- EPS
- ACDC N/A
- AUPH N/A
- Revenue
- ACDC $2,225,300,000.00
- AUPH $220,361,000.00
- Revenue This Year
- ACDC N/A
- AUPH $36.97
- Revenue Next Year
- ACDC N/A
- AUPH $16.43
- P/E Ratio
- ACDC N/A
- AUPH N/A
- Revenue Growth
- ACDC N/A
- AUPH 38.72
- 52 Week Low
- ACDC $5.16
- AUPH $4.71
- 52 Week High
- ACDC $9.75
- AUPH $10.67
- Technical
- Relative Strength Index (RSI)
- ACDC 60.12
- AUPH 45.91
- Support Level
- ACDC $7.25
- AUPH $8.89
- Resistance Level
- ACDC $7.33
- AUPH $9.31
- Average True Range (ATR)
- ACDC 0.41
- AUPH 0.34
- MACD
- ACDC 0.04
- AUPH -0.11
- Stochastic Oscillator
- ACDC 85.41
- AUPH 1.43
About ACDC ProFrac Holding Corp.
ProFrac Holding Corp is engaged in providing hydraulic fracturing, completion services, and other complementary products and services to upstream oil and gas companies engaged in the exploration and production of North American unconventional oil and natural gas resources. Its operations are focused in West Texas, East Texas/Louisiana, South Texas, Oklahoma, Uinta, and Appalachian. The company operates in three segments: stimulation services, manufacturing, and proppant production. Stimulation services, which generate the majority of the revenue for the company operate a fleet of mobile hydraulic fracturing units and other auxiliary equipment that generates revenue by providing stimulation services.
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.